Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

TeleHealth Med vs TelePeptide

By GLP-1 ScorecardUpdated

TeleHealth MedFactor scores not reassessed.
Site position #222

Higher score

TelePeptideFactor scores not reassessed.
Site position #296

Lower score

Score comparison

TeleHealth Med has the higher recorded score — 66.1/100 to 62.3/100.

TeleHealth Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TeleHealth Med (TeleHealth Med, Inc.) is a Georgia-based telehealth weight-loss platform offering compounded semaglutide and tirzepatide in both injectable and sublingual forms through US-licensed clinicians and 503A pharmacies.

Before you choose

Before comparing the headline prices, the TeleHealth Med review and the TelePeptide review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.

If neither one fits, TeleHealth Med vs Tyde Wellness and bmiMD vs TelePeptide compare each of them with another graded program, and the list of alternatives to TeleHealth Med ranks the programs closest to TeleHealth Med on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.

Of the sellers that pay us a commission, the WellMedr review covers one graded close to these two, at 63.2/100. That relationship never changes a grade, and the review lists what we could not verify.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueTeleHealth Med +30
74
44
Dose & formulationTelePeptide +12
63
75
Clinical oversightTelePeptide +11
76
87
Labs & monitoringTelePeptide +2
52
54
FulfillmentTelePeptide +14
63
77
Contract termsTeleHealth Med +35
55
20
TeleHealth Med · top barTelePeptide · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricTeleHealth MedTelePeptide
WeighScore66.1/10062.3/100
GradeCC
Site position#222#296
Semaglutide$147/mo (starting dose, compounded)$149/mo (monthly billing; $1,428 for 12 months; compounded injection)
TirzepatideNot disclosed$249/mo (monthly billing; $2,568 for 12 months; compounded injection)
CoverageCoverage not publishedCoverage not published
Brand-name accessNot confirmedNot confirmed
Oral / sublingualYesYes
TeleHealth Med

Site position #222 · C

Factor scores not reassessed.

Strengths

  • Corporate entity disclosed (TeleHealth Med, Inc.) — clearer accountability than undisclosed competitors
  • Publishes the FDA compounded-medication disclaimer
  • 503A pharmacy designation stated in the FAQ
  • Honest disclosure that testimonials are compensated and results aren't independently verified
  • Both injectable and sublingual forms offered

What to consider

  • Specific 503A pharmacy partner not named
  • LegitScript ID number not shown in text — only a verification link
  • Full states-served list not disclosed
  • Named medical director not disclosed
  • Dose tiers beyond the $147/mo starting price not published
TelePeptide

Site position #296 · C

Factor scores not reassessed.

Strengths

  • LegitScript-certified (seal ID 49966407); 503A-licensed compounding pharmacies
  • All-inclusive from about $119/mo on a 12-month plan ($1,428) — physician eval, Rx, medication and shipping
  • Publishes 1-, 3-, 6- and 12-month prices for both injections
  • 24/7 care team messaging + regular check-ins + dosage adjustments included at every tier
  • 48 states + DC coverage (excludes only AK + MS); no insurance required; cancel anytime

What to consider

  • Compounded medications are not FDA-approved; no pharmacy partner named publicly
  • Monthly billing costs more — $149/mo versus about $119/mo on the 12-month plan for semaglutide; the best rate requires annual prepay
  • Labs not included in any plan
  • Founder disclosed by first name only (Ahmed); no physician names or clinical leadership disclosed publicly
  • Tirzepatide injectable at $249/mo (monthly billing) is above the compounded market average

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.

← Back to the scorecard